Transcriptomic and proteomic analyses have consistently revealed that DHODH is highly expressed in rapidly proliferating tumors, including hepatocellular carcinoma, colorectal cancer, glioblastoma, neuroblastoma, breast cancer, melanoma, and renal cell carcinoma [13,14,15,16,17]. Here, DHODH is linked to neuroblastoma.